STAND NUMBER: 676
Scandinavian ChemoTech AB
Following extensive research and development, ChemoTech recently launched the IQwave™ - the next generation of electroporation devices, in India, Philippines and Kenya, with gentle yet effective and flexible treatment capabilities. The IQwave™ has been developed to achieve positive clinical outcomes on a level previously not possible. The IQwave™ is intended to be used in performing Electrochemotherapy, a treatment approved for the treatment of a wide range of tumours and included in the NICE Guidelines.
ChemoTech is a Scandinavian company based at Medicon Village in Lund, Sweden. The company`s founders have extensive experience of cancer treatment through surgical oncology and clinical development. The company is dedicated to using its unique patented know-how to develop innovation in cancer care.